Navigation Links
Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
Date:7/29/2010

w a personalized approach to patient treatment by making it possible for the first time, to select a clinical dose capable of saturating 5-HT2A receptors while permitting the "dialing in" of an optimal amount of dopamine receptor modulation by simple dose adjustments using a single drug.  At low doses, ITI-007 improves sleep in patients suffering from insomnia characterized by difficulty maintaining sleep throughout the night, without producing daytime sedation.  In contrast to most other antipsychotic medications, ITI-007 is non-sedating, increasing sleep and decreasing wakefulness during the night with no daytime drowsiness or next-day hangover effects.  At higher doses, the ability to optimize the level of dopamine receptor modulation holds promise for the reduction of acute as well as chronic psychotic symptoms in patients with schizophrenia without incurring motor disturbances and other deleterious side effects. Importantly, ITI-007 also has a low propensity, much lower than currently marketed antipsychotic drugs, to bind receptors that mediate deleterious cardiovascular events, profound sedation and rapid and significant weight gain. In addition, the wide separation of affinity at 5-HT2A and D2 receptors may allow for administration of the appropriate amount of dopamine modulation for antipsychotic maintenance therapy and the treatment of bipolar disorder, posttraumatic stress disorder, behavioral disturbances in Alzheimer's disease, and autism. The serotonin reuptake inhibition allows for additional antidepressant efficacy for the treatment of schizoaffective disorder, co-morbid depression, and/or as a stand-alone treatment for major depressive disorder (MDD).

ABOUT INTRA-CELLULAR THERAPIES

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company developing novel drugs for the treatment of diseases and disorders of the Central Nervous System (CNS).  Building
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
3. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
4. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
5. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
6. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
7. Intra-Cellular Therapies Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs
8. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
9. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
10. TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics
11. Drug in New Class of Targeted Therapies Shows Early Promise Against Blood-Related Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, May 7, 2015 to discuss ... Interested parties may access the live conference ...
(Date:4/30/2015)... , April 30, 2015  Cumberland Pharmaceuticals Inc. ... release first quarter 2015 financial results after the market ... and live Internet webcast will be held on Thursday, ... discuss the results. To participate in the ... (for international callers).  A rebroadcast of the teleconference will ...
(Date:4/30/2015)... 30, 2015 Perrigo Company plc (NYSE: PRGO ; ... C. Papa will present at the 2015 Deutsche Bank 40 ... 6, 2015 at the InterContinental Hotel in Boston ... Chairman, President and CEO Joseph C. Papa will present ... 1:00PM PT on Tuesday, May 12, 2015 at the Encore at ...
Breaking Medicine Technology:IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... , HOUSTON , Feb. ... "Frank" De Santiago. On January 29 , De Santiago ... at Texas Children,s Heart Center . De Santiago made ... discharged from a pediatric hospital with an implanted mechanical heart ...
... , WASHINGTON , Feb. 12 ... President Bill Clinton a quick recovery following his ... patients, Mr. Clinton has communicated a desire to return to ... surgery to open the chest, most patients who receive coronary ...
Cached Medicine Technology:Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 2Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 3SCAI Statement on the Hospitalization of Former President Bill Clinton 2
(Date:5/2/2015)... Aliso Viejo, CA (PRWEB) May 02, 2015 ... made exclusively for use in Final Cut Pro X. ... ready for use in Final Cut Pro X . ... a single keyframe with Pixel Film Studios' ProText Kinetic 2. ... drop. Start by staggering two ProText Kinetic presets in ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response ... Kare Visits offers relief for caregivers by visiting loved ones ... According to the Caregiver Action Network, eight in ten caregivers ... a week caring for an elderly or disabled loved one. ... nurse, a caregiver is now empowered to schedule an on ...
(Date:5/1/2015)... Islands, BWI (PRWEB) May 02, 2015 ... It is http://www.thevenetiangracebay.com , and it is ... incorporates the stunning white and attractive turquoise hues of ... of Google, sixty seven percent of leisure travelers used ... showed that smartphones were used in the planning and ...
(Date:5/1/2015)... 01, 2015 TROY Healthcare Solutions is ... Regional User Group (RUG) Conference in Atlanta, GA from ... User Group Conference provides a forum for client-to-client presentations, ... all aspects of electronic medical record operations, as well ... applications. , In addition to sponsoring the event, TROY ...
(Date:5/1/2015)... May 01, 2015 The Quail Creek Relay ... Cancer Society. Since 2001, the Quail Creek Relay team has ... host events throughout the year, including their biggest event, January’s ... Ball Drop. , Quail Creek Relay for Life team ... cancer. Kate Kerwin, fitness director, states, “I was hooked when ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... Dec. 28 Lincare Holdings,Inc. (Nasdaq: LNCR ) ... U.S.,Securities and Exchange Commission (the "SEC") a resale shelf ... S-3 pursuant to the terms,of a registration rights agreement ... the sale of its $275 million principal amount of,convertible ...
... (Amex: CPD ) announced today that the US ... the Company,s,Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride,Tablets, ... (Cetirizine HCl)., Cetirizine HCl, which will be marketed ... mg and 10 mg, is an antihistamine drug, which ...
... MYL ),today announced that Mylan Pharmaceuticals Inc. has received ... for its Abbreviated New,Drug Application (ANDA) for Cetirizine Hydrochloride ... Tablets are the generic version of Pfizer,s Zyrtec(R),Tablets, which ... 12,months ending Sept. 30, 2007., This product will ...
... Laser surgery to correct vision problems has been ... is typically used to correct low to moderate myopia, ... myopia corrections. Although over 18 million LASIK procedures have ... the maximum correction possible and efficacy with this technique. ...
... with patients than are other doctors, study finds , , ... issues of spirituality and faith when interacting with patients, ... study finds. , In fact, more than 90 percent ... to ask patients about their religious faith or spirituality, ...
... National Drug,Intelligence Center (NDIC), a component of ... center for strategic drug intelligence, has released,the ... presents an analysis of key trends and ... in the,United States. The assessment also offers ...
Cached Medicine News:Health News:Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R) 2Health News:LASIK works well, according to long-term study of highly myopic patients 2Health News:Most Psychiatrists Open to Discussing Spiritual Concerns 2Health News:Most Psychiatrists Open to Discussing Spiritual Concerns 3Health News:National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment 2
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
This wrap around apron features a uniquely designed orthopedic wide belt that is integrated directly on the apron....
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Unique criss-cross strapping. The MSV-10 is our most popular model. Extra wide Velcro ensures a wide variety of adjustments and easy closing....
Medicine Products: